← Leaderboards
Carol J Wilson
Consensus Pharmaceuticals, Inc.
$1,706,889
Attributed
$1,706,889
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,706,889 · 3
By mechanism
R44$1,607,854 · 2
R43$99,035 · 1
Top collaborators
No co-investigators on record.
Most similar at Consensus Pharmaceuticals, Inc.
Same institution · by research overlap
- Barbara C Natke$99,172
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsProtein BindingPeptide LibraryAntiaids AgentCytokine ReceptorsHuman Immunodeficiency VirusHiv Envelope Protein Gp120BaculoviridaeTransfection /Expression VectorDrug Design /Synthesis /ProductionMolecular CloningProtein PurificationProtein SequencePeptide Chemical SynthesisDrug Screening /EvaluationBiological Signal TransductionLigandsPeptide StructurePharmacokineticsAntiviral AgentsHigh Throughput Technology
Grant awards (5)
Anti-HIV Pharmaceutical Targeting CXCR4$546,776
R44 · FY2002 · AI
Anti-HIV Pharmaceutical Targeting CCR5$469,600
R44 · FY2002 · AI
Anti-HIV Pharmaceutical Targeting CCR5$492,950
R44 · FY2001 · AI
Anti-HIV Pharmaceutical Targeting CXCR4$98,528
R44 · FY2001 · AI
ANTI-HIV PHARMACEUTICAL TARGETING CCR5$99,035
R43 · FY2000 · AI